Value of Midkine as a Diagnostic Serum Marker in Hepatocellular Carcinoma

Evaluation of serum Midkine as a Diagnostic Marker for Hepatocellular Carcinoma in Hepatitis C virus Patients with Liver Cirrhosis

Clinical Significance of Serum Midkine Level as a Biomarker in Diagnosis of Hepatocellular Carcinoma

Evaluation of Serum Midkine as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients

Role of Serum Midkine Level as a Diagnostic Biomarker for Very Early and Early Hepatocellular Carcinoma

Evaluation of serum Midkine as a novel biomarker for the diagnosis of hepatocellular carcinoma

MOLECULAR EVALUATION OF MIDIKINE (MDK) AS A POTENTIAL BIOMARKER TODETECT HEPATOCELLULAR CARCINOMA

SERUM LEVEL OF HEPCIDIN IN CIRRHOTIC PATIENTS AS A MARKER FOR HEPATOCELLULAR CARCINOMA

Significance of Serum Hepatocyte Growth Factor Level in Diagnosis of Hepatocellular Carcinoma

VALUE OF SERUM ALPHA L FUCOSIDASE LEVEL AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA BEFORE AND AFTER CHEMO-EMBOLIZATION AND RADIO-FREQUENCY, A PROSPECTIVE STUDY